$ACUR
ACURA PHARMACEUTICALS, INC

2016 Q2 Form 10-Q Financial Statement

#000114420416117260 Filed on August 08, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $257.0K $341.0K
YoY Change -24.63% 874.29%
Cost Of Revenue $100.0K $100.0K
YoY Change 0.0% 150.0%
Gross Profit $160.0K $240.0K
YoY Change -33.33% -2500.0%
Gross Profit Margin 62.26% 70.38%
Selling, General & Admin $1.808M $2.083M
YoY Change -13.2% 8.72%
% of Gross Profit 1130.0% 867.92%
Research & Development $1.403M $511.0K
YoY Change 174.56% -60.11%
% of Gross Profit 876.88% 212.92%
Depreciation & Amortization $90.00K $80.00K
YoY Change 12.5% 166.67%
% of Gross Profit 56.25% 33.33%
Operating Expenses $3.211M $2.594M
YoY Change 23.79% -21.56%
Operating Profit -$3.079M -$2.398M
YoY Change 28.4% -26.71%
Interest Expense $233.0K $301.0K
YoY Change -22.59% -0.33%
% of Operating Profit
Other Income/Expense, Net -$209.0K -$265.0K
YoY Change -21.13% 6.43%
Pretax Income -$3.288M -$2.663M
YoY Change 23.47% -24.37%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.288M -$2.663M
YoY Change 23.47% -24.37%
Net Earnings / Revenue -1279.38% -780.94%
Basic Earnings Per Share -$0.28 -$0.28
Diluted Earnings Per Share -$0.28 -$0.28
COMMON SHARES
Basic Shares Outstanding 11.86M shares 49.23M shares
Diluted Shares Outstanding 11.86M shares 9.847M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.780M $10.92M
YoY Change -37.91% -37.11%
Cash & Equivalents $765.0K $1.268M
Short-Term Investments $3.520M $9.651M
Other Short-Term Assets $490.0K $620.0K
YoY Change -20.97% -16.22%
Inventory $180.0K $217.0K
Prepaid Expenses
Receivables $211.0K $110.0K
Other Receivables $10.00K $50.00K
Total Short-Term Assets $7.678M $11.92M
YoY Change -35.61% -36.35%
LONG-TERM ASSETS
Property, Plant & Equipment $1.010M $1.121M
YoY Change -9.9% 20.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $180.0K
YoY Change -100.0% -10.0%
Total Long-Term Assets $2.544M $3.038M
YoY Change -16.26% -2.85%
TOTAL ASSETS
Total Short-Term Assets $7.678M $11.92M
Total Long-Term Assets $2.544M $3.038M
Total Assets $10.22M $14.96M
YoY Change -31.68% -31.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $164.0K $261.0K
YoY Change -37.16% 128.95%
Accrued Expenses $804.0K $863.0K
YoY Change -6.84% -40.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.629M $2.419M
YoY Change 8.68% 407.13%
Total Short-Term Liabilities $3.943M $3.852M
YoY Change 2.36% 61.92%
LONG-TERM LIABILITIES
Long-Term Debt $4.165M $6.629M
YoY Change -37.17% -27.79%
Other Long-Term Liabilities $480.0K $290.0K
YoY Change 65.52%
Total Long-Term Liabilities $4.165M $6.629M
YoY Change -37.17% -27.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.943M $3.852M
Total Long-Term Liabilities $4.165M $6.629M
Total Liabilities $8.585M $10.77M
YoY Change -20.3% -6.82%
SHAREHOLDERS EQUITY
Retained Earnings -$374.0M -$363.7M
YoY Change 2.81% 1.97%
Common Stock $375.6M $367.9M
YoY Change 2.08% 0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.637M $4.190M
YoY Change
Total Liabilities & Shareholders Equity $10.22M $14.96M
YoY Change -31.68% -31.56%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$3.288M -$2.663M
YoY Change 23.47% -24.37%
Depreciation, Depletion And Amortization $90.00K $80.00K
YoY Change 12.5% 166.67%
Cash From Operating Activities -$3.570M -$2.670M
YoY Change 33.71% -13.03%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$210.0K
YoY Change -95.24% -89.6%
Acquisitions
YoY Change
Other Investing Activities $4.180M $680.0K
YoY Change 514.71% -383.33%
Cash From Investing Activities $4.170M $470.0K
YoY Change 787.23% -120.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -620.0K -360.0K
YoY Change 72.22%
NET CHANGE
Cash From Operating Activities -3.570M -2.670M
Cash From Investing Activities 4.170M 470.0K
Cash From Financing Activities -620.0K -360.0K
Net Change In Cash -20.00K -2.560M
YoY Change -99.22% -51.97%
FREE CASH FLOW
Cash From Operating Activities -$3.570M -$2.670M
Capital Expenditures -$10.00K -$210.0K
Free Cash Flow -$3.560M -$2.460M
YoY Change 44.72% 134.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3516000 USD
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
10837000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
211000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
14135000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1535000 USD
CY2016Q2 us-gaap Assets
Assets
10222000 USD
CY2016Q2 us-gaap Other Assets
OtherAssets
0 USD
CY2015Q4 us-gaap Other Assets
OtherAssets
175000 USD
CY2016Q2 us-gaap Interest Payable Current
InterestPayableCurrent
49000 USD
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3943000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3244000 USD
CY2016Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4165000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5430000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
9061000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
118000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
375157000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-367310000 USD
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
26000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-65000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1637000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
7900000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10222000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16961000 USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2629000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2320000 USD
CY2016Q2 us-gaap Royalty Revenue
RoyaltyRevenue
30000 USD
CY2015Q2 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
94000 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
91000 USD
CY2016Q2 us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
CY2015Q2 us-gaap License And Services Revenue
LicenseAndServicesRevenue
250000 USD
CY2016Q2 us-gaap Revenues
Revenues
257000 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
7678000 USD
CY2015Q4 acur Sales Returns Liability Current
SalesReturnsLiabilityCurrent
205000 USD
CY2016Q2 us-gaap Liabilities
Liabilities
8585000 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
118000 USD
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
375475000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-373982000 USD
CY2016Q2 acur Longterm Portion Of Accrued Interest
LongtermPortionOfAccruedInterest
477000 USD
CY2015Q4 acur Longterm Portion Of Accrued Interest
LongtermPortionOfAccruedInterest
387000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1638000 USD
CY2015Q4 us-gaap Assets
Assets
16961000 USD
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
164000 USD
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
804000 USD
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
34000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
110000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
564000 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45000 USD
CY2016Q2 acur Sales Returns Liability Current
SalesReturnsLiabilityCurrent
263000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2417000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4054000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6217000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-886000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
48000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
71000 USD
us-gaap Interest Expense
InterestExpense
482000 USD
us-gaap Interest Expense
InterestExpense
609000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1424000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
91000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6581000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1424000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-455000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-538000 USD
CY2015Q2 us-gaap Revenues
Revenues
341000 USD
CY2016Q2 acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
99000 USD
CY2015Q2 acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
98000 USD
CY2016Q2 us-gaap Inventory Write Down
InventoryWriteDown
26000 USD
CY2015Q2 us-gaap Inventory Write Down
InventoryWriteDown
47000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1403000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
511000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1808000 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2083000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3079000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2398000 USD
CY2016Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
21000 USD
CY2015Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
36000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
233000 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
301000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3288000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2663000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-3288000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-2663000 USD
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
21000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-31000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3267000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2694000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-209000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-265000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11858000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11858000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9847000 shares
CY2016Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
133000 USD
CY2015Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
0 USD
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
2739000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Royalty Revenue
RoyaltyRevenue
47000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
201000 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
201000 USD
us-gaap Inventory Write Down
InventoryWriteDown
26000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6672000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1424000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
91000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
300000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
67000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
59000 USD
acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
26000 USD
acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
307000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
300000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
311000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
78000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
97000 USD
acur Amortization Of Bond Premium In Marketable Securities
AmortizationOfBondPremiumInMarketableSecurities
29000 USD
acur Amortization Of Bond Premium In Marketable Securities
AmortizationOfBondPremiumInMarketableSecurities
76000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
103000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
103000 USD
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-24000 USD
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-13000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-68000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
220000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
74000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
152000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-215000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
54000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
44000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
240000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
295000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-353000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5485000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-503000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
139000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
96000 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
0 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1034000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-355000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
780000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
494000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
774000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1268000 USD
us-gaap Interest Paid
InterestPaid
265000 USD
us-gaap Interest Paid
InterestPaid
414000 USD
acur Provision For Sales Returns
ProvisionForSalesReturns
58000 USD
acur Provision For Sales Returns
ProvisionForSalesReturns
195000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7362000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1595000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
7299000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1352000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
1034000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
573000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
128000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33000 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 USD
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-21000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
7000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
23000 USD
CY2016Q2 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
2500000 USD
CY2016Q2 acur Cash Cash Equivalent And Marketable Securities
CashCashEquivalentAndMarketableSecurities
4300000 USD
CY2016Q2 acur Working Capital
WorkingCapital
1200000 USD
CY2015Q2 us-gaap Retail Related Inventory
RetailRelatedInventory
260000 USD
CY2014Q2 us-gaap Retail Related Inventory
RetailRelatedInventory
260000 USD
CY2015Q4 acur Sales Returns Liability
SalesReturnsLiability
205000 USD
CY2016Q2 acur Sales Returns Liability
SalesReturnsLiability
263000 USD
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
255000 USD
CY2015Q1 us-gaap Deferred Sales Inducements Additions
DeferredSalesInducementsAdditions
314000 USD
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1300000 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3100000 USD
CY2016Q2 acur Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
0 USD
CY2015Q4 acur Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
400000 USD
CY2016Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
3500000 USD
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
10900000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
100000 USD
CY2016Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
98000 USD
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
0 USD
CY2016Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
116000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
346000 USD
CY2016Q2 us-gaap Inventory Gross
InventoryGross
214000 USD
CY2015Q4 us-gaap Inventory Gross
InventoryGross
346000 USD
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
32000 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
70000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
CY2015Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
47000 USD
acur Inventory Reserve Expense Raw And Packagings
InventoryReserveExpenseRawAndPackagings
0 USD
acur Inventory Reserve Expense Raw And Packagings
InventoryReserveExpenseRawAndPackagings
260000 USD
CY2016Q2 acur Accrued Cost Sharing Expenses
AccruedCostSharingExpenses
278000 USD
CY2015Q4 acur Accrued Cost Sharing Expenses
AccruedCostSharingExpenses
0 USD
CY2016Q2 acur Accrued Cost Sharing Expenses Clinical Studies
AccruedCostSharingExpensesClinicalStudies
100000 USD
us-gaap Depreciation
Depreciation
59000 USD
us-gaap Depreciation
Depreciation
68000 USD
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2817000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2754000 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1808000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1741000 USD
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
132000 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
101000 USD
CY2016Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
149000 USD
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
171000 USD
CY2016Q2 acur Other Accrued Taxes Current
OtherAccruedTaxesCurrent
6000 USD
CY2015Q4 acur Other Accrued Taxes Current
OtherAccruedTaxesCurrent
6000 USD
CY2016Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
15000 USD
CY2015Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
15000 USD
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
63000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
64000 USD
CY2016Q2 acur Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
121000 USD
CY2015Q4 acur Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
92000 USD
CY2016Q2 acur Marketing Advertising And Promotion
MarketingAdvertisingAndPromotion
40000 USD
CY2015Q4 acur Marketing Advertising And Promotion
MarketingAdvertisingAndPromotion
115000 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10000000 USD
CY2013Q4 acur Debt Default Long Term Debt Percentage
DebtDefaultLongTermDebtPercentage
0.1335 pure
CY2015Q1 acur Debt Instrument Cash Maintenance
DebtInstrumentCashMaintenance
2500000 USD
CY2016Q2 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
50000 USD
acur Debt Consulting Placement Fee
DebtConsultingPlacementFee
100000 USD
acur Debt Instrument Classification Amount
DebtInstrumentClassificationAmount
0 USD
CY2015Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
8040000 USD
CY2016Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
7006000 USD
acur Additions To Debt Instrument Unamortized Discount
AdditionsToDebtInstrumentUnamortizedDiscount
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
51000 USD
CY2015Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
193000 USD
CY2016Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
142000 USD
acur Amortization Expense Of Debt Instrument Issuance Costs
AmortizationExpenseOfDebtInstrumentIssuanceCosts
27000 USD
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
6794000 USD
CY2015Q4 acur Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
97000 USD
CY2016Q2 acur Debt Instrument Issuance Costs
DebtInstrumentIssuanceCosts
70000 USD
acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
63000 USD
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
34000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
404000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
512000 USD
CY2016Q2 acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
25000 USD
CY2015Q2 acur Interest Expense Debt Discount
InterestExpenseDebtDiscount
33000 USD
CY2016Q2 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
13000 USD
CY2015Q2 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
17000 USD
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
195000 USD
CY2015Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
251000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1287000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2741000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2978000 USD
CY2013Q4 us-gaap Secured Debt
SecuredDebt
10000000 USD
CY2016Q2 acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
150000 USD
CY2015Q2 acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
151000 USD
acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
300000 USD
acur Share Based Compensation Expense Recognized In Operations
ShareBasedCompensationExpenseRecognizedInOperations
311000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
6000 USD
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
471000 USD
CY2016Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
23800 USD
acur Share Based Compensation Arrangement Share Based Payment Shares Reserved For Future Distribution
ShareBasedCompensationArrangementShareBasedPaymentSharesReservedForFutureDistribution
2400 shares
CY2015 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
52800000 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
155200000 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2015 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2000000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
ACURA PHARMACEUTICALS, INC
dei Entity Central Index Key
EntityCentralIndexKey
0000786947
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
ACUR
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11833801 shares
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
91000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
465000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
362000 USD
CY2016Q2 acur Debt Instrument Issuance Cost
DebtInstrumentIssuanceCost
70000 USD
CY2015Q4 acur Debt Instrument Issuance Cost
DebtInstrumentIssuanceCost
97000 USD
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11834000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11801000 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11834000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11801000 shares
acur Inventory Destruction Finished Goods
InventoryDestructionFinishedGoods
64000 USD
acur Inventory Destruction Finished Goods
InventoryDestructionFinishedGoods
0 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1500000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
14000 USD
acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
0 USD
acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
225000 USD
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11833000 shares
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-175000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
175000 USD
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
9811000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
24000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
14000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
14000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
9000 shares
us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
250000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
8000 USD
CY2016Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11834000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
9833000 shares
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1302000 shares
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
977000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1302000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
977000 shares
acur Inventory Reserve Expense Finished Goods
InventoryReserveExpenseFinishedGoods
26000 USD
acur Inventory Reserve Expense Finished Goods
InventoryReserveExpenseFinishedGoods
47000 USD
acur Inventory Reserve Expense
InventoryReserveExpense
96000 USD
acur Inventory Reserve Expense
InventoryReserveExpense
307000 USD
acur Inventory Destruction Raw And Packaging Material
InventoryDestructionRawAndPackagingMaterial
0 USD
acur Inventory Destruction Raw And Packaging Material
InventoryDestructionRawAndPackagingMaterial
260000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0 pure
CY2015Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
60000 shares
acur Additions To Debt Instrument Unamortized Discount
AdditionsToDebtInstrumentUnamortizedDiscount
33000 USD
acur Agreement Termination Notice Description
AgreementTerminationNoticeDescription
Egalet may terminate the Egalet Agreement for convenience on 120 days prior written notice, which termination may not occur prior to the second anniversary of Egalet's launch of Oxaydo. Termination does not affect a party's rights accrued prior thereto, but there are no stated payments in connection with termination other than payments of obligations previously accrued. For all terminations (but not expiration), the Egalet Agreement provides for the transition of development and marketing of Oxaydo from Egalet to us, including the conveyance by Egalet to us of the trademarks and all regulatory filings and approvals relating to Oxaydo, and for Egalet's supply of Oxaydo for a transition period.
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2016Q2 acur Accrued Cost Sharing Expenses Post Marketing Study
AccruedCostSharingExpensesPostMarketingStudy
200000 USD

Files In Submission

Name View Source Status
0001144204-16-117260-index-headers.html Edgar Link pending
0001144204-16-117260-index.html Edgar Link pending
0001144204-16-117260.txt Edgar Link pending
0001144204-16-117260-xbrl.zip Edgar Link pending
acur-20160630.xml Edgar Link completed
acur-20160630.xsd Edgar Link pending
acur-20160630_cal.xml Edgar Link unprocessable
acur-20160630_def.xml Edgar Link unprocessable
acur-20160630_lab.xml Edgar Link unprocessable
acur-20160630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v444832_10q.htm Edgar Link pending
v444832_ex31-1.htm Edgar Link pending
v444832_ex31-2.htm Edgar Link pending
v444832_ex32-1.htm Edgar Link pending